These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37206871)
1. Nitrous oxide: a unique official French addictovigilance national survey. Guerlais M; Aquizerate A; Lionnet A; Daveluy A; Duval M; Gérardin M; Istvan M; Laforgue EJ; Victorri-Vigneau C; Front Public Health; 2023; 11():1167746. PubMed ID: 37206871 [TBL] [Abstract][Full Text] [Related]
2. Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J; Therapie; 2020; 75(4):343-354. PubMed ID: 32660776 [TBL] [Abstract][Full Text] [Related]
3. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)]. Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700 [TBL] [Abstract][Full Text] [Related]
4. Nitrous oxide: What do we know about its use disorder potential? Results of the French Monitoring Centre for Addiction network survey and literature review. Fidalgo M; Prud'homme T; Allio A; Bronnec M; Bulteau S; Jolliet P; Victorri-Vigneau C Subst Abus; 2019; 40(1):33-42. PubMed ID: 30913001 [No Abstract] [Full Text] [Related]
6. Chemsex practice in France: An update in Addictovigilance data. Batisse A; Eiden C; Deheul S; Monzon E; Djezzar S; Peyrière H Fundam Clin Pharmacol; 2022 Apr; 36(2):397-404. PubMed ID: 34494320 [TBL] [Abstract][Full Text] [Related]
7. Addictovigilance in women, the hidden part of the iceberg? Lapeyre-Mestre M Therapie; 2023; 78(2):157-164. PubMed ID: 36280399 [TBL] [Abstract][Full Text] [Related]
8. Erratum: Nitrous oxide: a unique official French addictovigilance national survey. Frontiers Production Office Front Public Health; 2023; 11():1235720. PubMed ID: 37469693 [TBL] [Abstract][Full Text] [Related]
9. Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels. Largeau B; Karam A; Potey C; Caous AS; Tard C; Carton L; Kuchcinski G; Gautier S; Deheul S; Bordet R Eur J Neurol; 2022 Aug; 29(8):2173-2180. PubMed ID: 35460312 [TBL] [Abstract][Full Text] [Related]
10. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]. Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770 [TBL] [Abstract][Full Text] [Related]
11. PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population. Gérardin M; Couec ML; Grall-Bronnec M; Feuillet F; Wainstein L; Rousselet M; Pinot ML; Perrouin F; Bonnot O; Drouineau MH; Jolliet P; Victorri-Vigneau C BMC Psychiatry; 2015 Nov; 15():281. PubMed ID: 26573686 [TBL] [Abstract][Full Text] [Related]
12. Signal identification in addictovigilance: the functioning of the French system. Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A Therapie; 2015; 70(2):113-31. PubMed ID: 25858567 [TBL] [Abstract][Full Text] [Related]
13. Does vitamin B12 deficiency explain psychiatric symptoms in recreational nitrous oxide users? A narrative review. Paulus MC; Wijnhoven AM; Maessen GC; Blankensteijn SR; van der Heyden MAG Clin Toxicol (Phila); 2021 Nov; 59(11):947-955. PubMed ID: 34348072 [No Abstract] [Full Text] [Related]
14. The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. Zheng D; Ba F; Bi G; Guo Y; Gao Y; Li W J Neurol; 2020 Feb; 267(2):422-429. PubMed ID: 31655888 [TBL] [Abstract][Full Text] [Related]
15. Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France. Dufayet L; Caré W; Laborde-Casterot H; Chouachi L; Langrand J; Vodovar D Rev Med Interne; 2022 Jul; 43(7):402-405. PubMed ID: 35773094 [TBL] [Abstract][Full Text] [Related]
16. An update on zolpidem abuse and dependence. Victorri-Vigneau C; Gérardin M; Rousselet M; Guerlais M; Grall-Bronnec M; Jolliet P J Addict Dis; 2014; 33(1):15-23. PubMed ID: 24467433 [TBL] [Abstract][Full Text] [Related]
17. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network? Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596 [TBL] [Abstract][Full Text] [Related]
18. Psychiatric and Other Medical Manifestations of Nitrous Oxide Abuse: Implications From Case Series. Chien WH; Huang MC; Chen LY J Clin Psychopharmacol; 2020; 40(1):80-83. PubMed ID: 31809285 [TBL] [Abstract][Full Text] [Related]
19. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)]. Baumevieille M; Perri-Plandé J; Miremont-Salamé G; Daveluy A; Haramburu F Therapie; 2019 Jun; 74(3):375-382. PubMed ID: 30193805 [TBL] [Abstract][Full Text] [Related]
20. Thromboembolic complications following recreational use of nitrous oxide: A French Addictovigilance alert. Victorri-Vigneau C; Guerlais M; Jaulin E; ; Laforgue EJ; Pistorius MA Thromb Res; 2024 Sep; 241():109096. PubMed ID: 39024900 [No Abstract] [Full Text] [Related] [Next] [New Search]